Written by Keen Meds · Reviewed by Licensed Clinical Providers · March 1, 2026
Key Insight: Exogenous testosterone suppresses LH and FSH in virtually all men, reducing sperm production to very low or undetectable levels within 3 to 6 months. Spermatogenesis recovery after stopping TRT occurs in the majority of men but can take 6 to 24 months and is not guaranteed.
For men considering testosterone replacement therapy, the fertility question is among the most consequential practical concerns -- and among the most frequently under-discussed at the time of treatment initiation. The biology is straightforward but the implications are significant: testosterone replacement therapy reliably suppresses sperm production in virtually all men by disrupting the hormonal signals that the testes require for spermatogenesis. This effect is generally reversible after stopping therapy, but recovery is not instantaneous and is not guaranteed in every case. Understanding the mechanism, the timeline, the options available to preserve fertility while on TRT, and the factors that affect recovery is essential information for any man of reproductive age who is considering testosterone therapy.
The Mechanism: Why TRT Suppresses Sperm Production
The relationship between exogenous testosterone and fertility suppression is a direct consequence of HPG axis physiology. Understanding the mechanism requires understanding the role of two pituitary hormones: LH (luteinizing hormone) and FSH (follicle-stimulating hormone).
LH stimulates Leydig cells in the testes to produce testosterone. FSH stimulates Sertoli cells in the testes, which provide the physical and nutritional scaffolding that developing sperm cells require. Without adequate FSH and a high intratesticular testosterone environment (which is actually much higher inside the testes than in systemic circulation), the Sertoli cells cannot support spermatogenesis effectively.
The HPG axis operates on negative feedback: when testosterone levels are high, the hypothalamus reduces GnRH pulsatility and the pituitary reduces LH and FSH secretion. When a man takes exogenous testosterone, his blood testosterone levels rise. The HPG axis reads this elevation as a signal that testosterone is sufficient and reduces its output accordingly. LH and FSH both fall, often to very low or undetectable levels, within weeks of starting TRT.
With LH suppressed, Leydig cell stimulation ceases. The testes reduce their own testosterone production substantially. With FSH suppressed, Sertoli cell activity diminishes. The intratesticular testosterone environment, which depends on both local Leydig cell production and the hormonal signals that support it, drops dramatically even as systemic testosterone (from the exogenous source) is high. Sperm production requires this intratesticular environment -- it cannot function on systemically delivered testosterone alone.
The result is predictable and well-documented: sperm production falls to very low or undetectable (azoospermic) levels in the majority of men within 3 to 6 months of initiating TRT.
The Timeline: How Quickly Fertility Is Affected
The suppression of sperm production follows a predictable time course. Within the first few weeks of TRT, LH and FSH levels begin to fall. Within 3 months, most men show significantly reduced sperm counts. Within 6 months, many men are either severely oligospermic (very few sperm) or azoospermic (no sperm detected in ejaculate).
The degree of suppression varies by formulation and dose. Higher testosterone doses and formulations that produce higher peak testosterone levels (such as biweekly injectables) tend to produce more complete and faster suppression. Lower doses and formulations producing stable mid-physiological levels (such as daily transdermal spray) may produce somewhat less complete suppression in some men, though the effect on fertility is still substantial and should not be treated as a reliable contraception.
This suppression timeline means that men who want to conceive in the near term should not start TRT without explicitly planning around fertility. Waiting until sperm production has been suppressed for several months and then attempting conception is not a viable approach.
Recovery After Stopping TRT: What the Data Shows
The most important practical question for men of reproductive age is: if I start TRT and later want children, can I recover fertility by stopping?
The answer for most men is yes, but the recovery is not guaranteed, not fast, and not always complete.
In the largest published recovery data, approximately 67% to 90% of men who stop TRT recover spermatogenesis to levels sufficient for natural conception or assisted reproduction within 24 months. The range reflects genuine variability -- some men recover quickly and fully; others recover partially; a small percentage do not recover meaningful sperm production.
The timeline for recovery typically spans 6 to 18 months after stopping TRT, though some men take longer. The primary factors associated with longer recovery time or incomplete recovery are longer duration of TRT use, older age at the time of stopping, baseline spermatogenic function before starting TRT, and individual variation in HPG axis resilience.
Men who used TRT for one to two years generally have faster and more complete recovery than men who used it for five or more years. Younger men generally recover faster than older men. Men with pre-existing spermatogenic impairment before starting TRT may have more limited recovery because their baseline spermatogenic function was already compromised.
The Endocrine Society and BSSM guidelines both emphasize that fertility implications should be discussed explicitly with men of reproductive age before initiating TRT.
Options for Men Who Want Fertility and Testosterone Treatment
Several clinical strategies exist for men who have symptomatic hypogonadism and also want to preserve or maintain fertility.
Sperm banking before starting TRT is the most straightforward fertility preservation strategy. Before beginning testosterone therapy, a man can bank semen samples at a fertility clinic or sperm bank. This cryopreserved sperm can be used for intrauterine insemination (IUI) or in vitro fertilization (IVF) if needed in the future, regardless of whether TRT eventually suppresses spermatogenesis. For men who are certain they want biological children, sperm banking is the most reliable insurance.
hCG (human chorionic gonadotropin) combined with TRT is an approach that attempts to maintain intratesticular testosterone and some spermatogenesis while providing systemic testosterone replacement. hCG is a hormone that mimics LH -- it binds to LH receptors on Leydig cells and stimulates them to produce testosterone within the testes, even in the context of suppressed pituitary LH. By maintaining intratesticular testosterone levels through hCG, it is possible to preserve some degree of spermatogenesis alongside TRT. hCG also prevents or partially reverses testicular atrophy that typically accompanies TRT. This approach does not guarantee normal fertility but substantially improves the chances of maintaining sperm production during TRT.
Clomiphene citrate (clomid) is a selective estrogen receptor modulator that blocks estrogen's negative feedback on the hypothalamus and pituitary, causing them to secrete more LH and FSH. In men with secondary hypogonadism (where the problem is pituitary or hypothalamic drive rather than testicular failure), clomiphene can raise testosterone by stimulating the natural axis. Because it works by increasing LH and FSH rather than bypassing them, it preserves and may actually improve spermatogenesis. Clomiphene is not appropriate for all men -- it works only when the testes retain responsive Leydig cells -- but for suitable candidates it offers testosterone improvement without fertility compromise.
Post-cycle recovery protocols using hCG and/or clomiphene after stopping TRT can accelerate HPG axis recovery and spermatogenesis restoration. These approaches are not universally endorsed in standard clinical guidelines but are widely used in practice with reasonable supporting rationale.
Age Considerations and Timing
The fertility implications of TRT are most critical for men who have not yet completed their family or who anticipate wanting biological children within the next several years.
For men in their 20s and 30s who have not started a family, fertility preservation is an urgent conversation before any TRT initiation. This group should be offered sperm banking, hCG co-treatment options, and careful discussion of timing.
For men in their 40s who may want a child but are uncertain, the timeline is more compressed, and recovery from TRT takes on greater urgency if therapy is started. Sperm banking before starting is still the most reliable approach.
For men in their 50s and beyond who are certain they do not want biological children, fertility is less relevant to the TRT decision, though testicular atrophy and the psychological aspects of testicular size change may still be considerations worth discussing.
Frequently Asked Questions
Does testosterone therapy act as a reliable form of contraception?
No. While TRT suppresses sperm production substantially in most men, it does not reliably produce azoospermia in every man, and sperm counts can be unpredictable during the suppression period. Testosterone should not be relied upon as a contraceptive. Men who wish to avoid pregnancy while on TRT should use barrier contraception or ensure that alternative contraception is in place.
Can I use hCG to protect my fertility without telling my testosterone prescriber?
No. Adding hCG to your regimen requires a prescription and should be coordinated with your prescribing provider. Self-managing hormonal treatment without clinical oversight carries risks. hCG dosing, timing, and monitoring in the context of TRT require clinical judgment and lab monitoring of testosterone, LH, and estradiol to avoid side effects including excess estradiol elevation.
How do I know if my sperm production has recovered after stopping TRT?
A semen analysis with sperm count and motility assessment is the appropriate test. Most fertility specialists recommend waiting at least 3 to 6 months after stopping TRT before the first post-treatment semen analysis, as recovery is gradual. If the first post-treatment analysis is abnormal, follow-up analyses at 3- to 6-month intervals are appropriate until recovery is confirmed or alternative paths are pursued.
Should younger men avoid TRT if they want children someday?
Not necessarily -- but they should have a thorough fertility preservation discussion before starting. For a young man with confirmed hypogonadism causing significant quality-of-life impairment, treatment may be appropriate. The approach should include sperm banking before starting TRT, consideration of hCG co-treatment to maintain some spermatogenesis, and explicit planning around stopping TRT well in advance if natural conception is desired. This is a conversation that should happen with both a TRT prescriber and a reproductive specialist.
What This Means for Your Treatment Decisions
TRT's effect on fertility is predictable, significant, and manageable with appropriate advance planning. For men of reproductive age, the decision to start TRT should always include an explicit fertility preservation discussion. Options exist -- sperm banking, hCG co-treatment, and alternatives like clomiphene -- that allow symptomatic men to be treated while protecting their reproductive options.
Keen Meds connects you with licensed clinical providers for a telehealth evaluation and lab review. If your testosterone is clinically low, you may qualify for Testosterone Spray Rx.
